A detailed history of First City Capital Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, First City Capital Management, Inc. holds 26,381 shares of ABBV stock, worth $4.63 Million. This represents 2.69% of its overall portfolio holdings.

Number of Shares
26,381
Previous 27,104 2.67%
Holding current value
$4.63 Million
Previous $4.65 Million 12.07%
% of portfolio
2.69%
Previous 2.65%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$163.84 - $199.33 $118,456 - $144,115
-723 Reduced 2.67%
26,381 $5.21 Million
Q2 2024

Aug 13, 2024

SELL
$154.79 - $180.76 $233,732 - $272,947
-1,510 Reduced 5.28%
27,104 $4.65 Million
Q1 2024

May 22, 2024

SELL
$159.82 - $182.1 $224,706 - $256,032
-1,406 Reduced 4.68%
28,614 $5.21 Million
Q4 2023

Feb 07, 2024

BUY
$137.6 - $154.97 $62,332 - $70,201
453 Added 1.53%
30,020 $4.65 Million
Q3 2023

Oct 26, 2023

SELL
$133.59 - $154.65 $41,680 - $48,250
-312 Reduced 1.04%
29,567 $4.41 Million
Q2 2023

Jul 19, 2023

SELL
$132.51 - $164.9 $114,753 - $142,803
-866 Reduced 2.82%
29,879 $4.03 Million
Q1 2023

May 01, 2023

BUY
$144.61 - $166.54 $95,731 - $110,249
662 Added 2.2%
30,745 $4.9 Million
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $227,105 - $272,358
-1,642 Reduced 5.18%
30,083 $4.86 Million
Q3 2022

Oct 24, 2022

BUY
$134.21 - $153.93 $244,262 - $280,152
1,820 Added 6.09%
31,725 $4.26 Million
Q2 2022

Jul 21, 2022

SELL
$137.62 - $174.96 $12,385 - $15,746
-90 Reduced 0.3%
29,905 $4.58 Million
Q1 2022

May 04, 2022

SELL
$131.98 - $163.75 $7,654 - $9,497
-58 Reduced 0.19%
29,995 $4.86 Million
Q4 2021

Feb 07, 2022

SELL
$107.43 - $135.93 $138,906 - $175,757
-1,293 Reduced 4.12%
30,053 $4.23 Million
Q3 2021

Oct 28, 2021

BUY
$106.4 - $120.78 $249,614 - $283,349
2,346 Added 8.09%
31,346 $3.38 Million
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $55,235 - $61,535
525 Added 1.84%
29,000 $3.35 Million
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $472,523 - $520,191
4,619 Added 19.36%
28,475 $3.27 Million
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $1.08 Million - $1.45 Million
-13,362 Reduced 35.9%
23,856 $2.48 Million
Q3 2020

Nov 16, 2020

BUY
$85.91 - $100.83 $1.46 Million - $1.72 Million
17,051 Added 84.55%
37,218 $3.26 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $321,654 - $430,421
4,384 Added 27.78%
20,167 $1.98 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $6,192 - $9,387
96 Added 0.61%
15,783 $1.2 Million
Q4 2019

Feb 10, 2020

BUY
$72.13 - $90.25 $30,222 - $37,814
419 Added 2.74%
15,687 $1.39 Million
Q3 2019

Nov 13, 2019

SELL
$62.98 - $75.72 $3,149 - $3,786
-50 Reduced 0.33%
15,268 $1.16 Million
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $29,565 - $37,791
-450 Reduced 2.85%
15,318 $1.11 Million
Q1 2019

May 13, 2019

BUY
$77.14 - $90.79 $34,713 - $40,855
450 Added 2.94%
15,768 $1.27 Million
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $5,334 - $5,930
60 Added 0.39%
15,318 $1.45 Million
Q4 2017

Feb 12, 2018

SELL
$89.56 - $98.21 $37,077 - $40,658
-414 Reduced 2.64%
15,258 $1.48 Million
Q3 2017

Oct 31, 2017

SELL
$69.85 - $89.22 $6,845 - $8,743
-98 Reduced 0.62%
15,672 $1.39 Million
Q2 2017

Aug 14, 2017

BUY
N/A
15,770
15,770 $1.14 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track First City Capital Management, Inc. Portfolio

Follow First City Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First City Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First City Capital Management, Inc. with notifications on news.